Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-22-033306)

Filing Details

Accession Number:: 0000899243-22-033306
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-10-07 18:44:31
Reporting Period:: 2022-10-06

Accepted Time:: 2022-10-07 18:44:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1787400	Nkarta Inc.	NKTX	Pharmaceutical Preparations (2834)	474515206

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1853197	Ralph Brandenberger	C/O Nkarta, Inc. 6000 Shoreline Court, Suite 102 South San Francisco CA 94080	Chief Technical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-10-06	842	$3.89	8,642	No	4	M	Direct
Common Stock	Disposition	2022-10-06	842	$14.02	7,800	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2022-10-06	842	$0.00	842	$3.89

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,584		2029-09-05	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.